Yahoo Finance

Catheter Precision Announces the Start of Enrollment for the LockeT Compare Study

Fort Mill, S.C., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the ...
Nasdaq

Sobi and Selecta Biosciences announce topline data of SEL-212 from the phase 2 COMPARE study supporting the potential for important clinical improvement in patients with ...

STOCKHOLM and WATERTOWN, Mass., Sept. 30, 2020 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi™) (STO: SOBI) and Selecta Biosciences, Inc. (NASDAQ: SELB), today announced topline data for the ...
The PIE News

Comparison platform Talk Study launched

A new service allowing prospective international students to compare study abroad options according to student and alumni reviews and data has been launched in Vietnam. Named Talk Study, the new ...
Pharmabiz

Sobi, Selecta Biosciences announce positive data from phase 2 COMPARE study comparing SEL-212 to pegloticase in patients with chronic refractory gout

Swedish Orphan Biovitrum AB (publ) (Sobi) and Selecta Biosciences Inc, announced topline data for the phase 2 COMPARE study comparing the efficacy of SEL-212, a combination of Selecta's tolerogenic ...